Search Within

Jacqueline Bromberg

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (7)
Groups
  1. Breast Medicine Service (7)
  2. Center for Molecular Imaging and Biotechnology (7)
  3. Department of Medicine (7)
  4. GSK Faculty (7)
  5. Solid Tumor Oncology Division (7)
  6. Sloan Kettering Institute Postdocs (5)

More Groups

People
  1. Jason Lewis (3)
  2. Larry Norton (3)
  3. Serge Lyashchenko (3)
  4. Bradley Beattie (2)
  5. Clifford Hudis (2)
  6. Eva Burnazi (2)

More People

Years
  1. 2024 (1)
  2. 2020 (1)
  3. 2018 (1)
  4. 2016 (1)
  5. 2014 (2)
  6. 2011 (1)
Publications
  1. Clinical Breast Cancer (1)
  2. Clinical Cancer Research (1)
  3. Genome Research (1)
  4. Journal of Nuclear Medicine (1)
  5. Proceedings of the National Academy of Sciences of the United States of America (1)
  6. Radiology (1)

More Publications

Publishers
  1. American Association for Cancer Research (1)
  2. American Association for the Advancement of Science (1)
  3. Cold Spring Harbor Laboratory Press (1)
  4. Elsevier Inc. (1)
  5. National Academy of Sciences (1)
  6. Radiological Society of North America, Inc. (1)

More Publishers

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human evaluation of site-specifically labeled (89)Zr-pertuzumab in patients with HER2-positive breast cancer
    Journal Article

    Yeh, R.; O'Donoghue, J. A.; Jayaprakasam, V. S.; Mauguen, A.; Min, R.; Park, S.; Brockway, J. P.; Bromberg, J. F.; Zhi, W. I.; Robson, M. E.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • First-in-human trial of epichaperome-targeted PET in patients with cancer
    Journal Article

    Dunphy, M. P. S.; Pressl, C.; Pillarsetty, N.; Grkovski, M.; Modi, S.; Jhaveri, K.; Norton, L.; Beattie, B. J.; Zanzonico, P. B.; Zatorska, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • In vivo PET assay of tumor glutamine flux and metabolism: In-human trial of (18)F-(2S,4R)-4-fluoroglutamine
    Journal Article

    Dunphy, M. P. S.; Harding, J. J.; Venneti, S.; Zhang, H.; Burnazi, E. M.; Bromberg, J.; Omuro, A. M.; Hsieh, J. J.; Mellinghoff, I. K.; Staton, K.; more...
    Radiology (2018)

    Fulltext@MSK | Save
  • JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors
    Journal Article

    Gao, S. P.; Chang, Q.; Mao, N.; Daly, L. A.; Vogel, R.; Chan, T.; Liu, S. H.; Bournazou, E.; Schori, E.; Zhang, H.; more...
    Science Signaling (2016)

    Fulltext@MSK | Save
  • Linking signaling pathways to transcriptional programs in breast cancer
    Journal Article

    Osmanbeyoglu, H. U.; Pelossof, R.; Bromberg, J. F.; Leslie, C. S.
    Genome Research (2014)

    Fulltext@MSK | Save
  • Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis
    Journal Article

    Ortiz, B.; Fabius, A. W. M.; Wu, W. H.; Pedraza, A.; Brennan, C. W.; Schultz, N.; Pitter, K. L.; Bromberg, J. F.; Huse, J. T.; Holland, E. C.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2014)

    Fulltext@MSK | Save
  • Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Sparano, J. A.; Caravelli, J.; Santamauro, J.; Patil, S.; Abbruzzi, A.; Pellegrino, C.; Bromberg, J.; Dang, C.; Theodoulou, M.; more...
    Clinical Breast Cancer (2011)

    Fulltext@MSK | Save